Authors: Jiang, GC Stalewski, J Galyean, R Dykert, J Schteingart, C Broqua, P Aebi, A Aubert, ML Semple, G Robson, P Akinsanya, K Haigh, R Riviere, P Trojnar, J Junien, JL Rivier, JE

Citation: Gc. Jiang et al., GnRH antagonists: A new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6, J MED CHEM, 44(3), 2001, pp. 453-467

Authors: de Pinieux, G Legrier, ME Poirson-Bichat, F Courty, Y Bras-Goncalves, R Dutrillaux, AM Nemati, F Oudard, S Lidereau, R Broqua, P Junien, JL Dutrillaux, B Poupon, MF

Citation: G. De Pinieux et al., Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach, AM J PATH, 159(2), 2001, pp. 753-764

Authors: Raposinho, PD Broqua, P Hayward, A Akinsanya, K Galyean, R Schteingart, C Junien, JL Aubert, ML

Citation: Pd. Raposinho et al., Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat, NEUROENDOCR, 71(1), 2000, pp. 2-7

Authors: Raposinho, PD Castillo, E D'Alleves, V Broqua, P Pralong, FP Aubert, ML

Citation: Pd. Raposinho et al., Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes, ENDOCRINOL, 141(12), 2000, pp. 4419-4427

Authors: Raposinho, PD Broqua, P Pierroz, DD Hayward, A Dumont, Y Quirion, R Junien, JL Aubert, ML

Citation: Pd. Raposinho et al., Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype, ENDOCRINOL, 140(9), 1999, pp. 4046-4055

Authors: Broqua, P Wettstein, JG Rocher, MN Riviere, PJM Dahl, SG

Citation: P. Broqua et al., The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozine, EUR NEUROPS, 8(4), 1998, pp. 261-266